Grove Biopharma
Paul A. Bertin, Ph.D., co-founded Grove Biopharma, Inc. in 2020 and brings more than 15 years of startup and R&D management experience to the team. Prior to Grove, Dr. Bertin most recently served as Director of Innovation at Elevance where his product innovations contributed to greater than 20% of the total enterprise revenue, including a key fine chemical intermediate for peptide APIs from the metathesis of natural oils. Dr. Bertin is an inventor on 40 US patents and an author on 18 peer-reviewed publications. He received his Ph.D. in organic chemistry from Northwestern University for the design of metathesis-based polymer nanostructures for targeted drug delivery and his bachelor’s degrees in chemistry and business (decision sciences) from Miami University in Ohio.
Grove Biopharma
Grove is a seed-stage platform biotechnology company pioneering the discovery and development of an innovative class of biotherapeutics for challenging drug targets that address significant unmet medical needs.